Jazz Pharmaceuticals (JAZZ) Net Margin Growth (3y) (2014 - 2026)

Jazz Pharmaceuticals (JAZZ) Net Margin Growth (3y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,283.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -569.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 6,537.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Jazz Pharmaceuticals 15.78 Bn 13.93 Bn 934.80 Mn 1,953.00

Historic Data

Download Data
DateValue
Mar 31, 2026 1,953.00
Dec 31, 2025 4,167.00
Sep 30, 2025 2,415.00
Jun 30, 2025 -7,267.00
Mar 31, 2025 -1,100.00
Dec 31, 2024 2,117.00
Sep 30, 2024 2,632.00
Jun 30, 2024 6,497.00
Mar 31, 2024 -2,099.00
Dec 31, 2023 -1,080.00
Sep 30, 2023 -968.00
Jun 30, 2023 -967.00
Mar 31, 2023 3,744.00
Dec 31, 2022 -3,764.00
Sep 30, 2022 -2,103.00
Jun 30, 2022 -4,523.00
Mar 31, 2022 -1,623.00
Dec 31, 2021 -3,726.00
Sep 30, 2021 -3,783.00
Jun 30, 2021 -6,707.00